1988
DOI: 10.2337/diab.37.1.74
|View full text |Cite
|
Sign up to set email alerts
|

Specific Immunity to Streptozocin: Cellular Requirements for Induction of Lymphoproliferation

Abstract: The mechanism(s) of the immunological reactions involved in the pathogenesis of hyperglycemia induced by multiple intraperitoneal injections of subdiabetogenic doses of streptozocin (STZ) in mice remains to be elucidated. We found that STZ can act as a hapten in vivo by using the popliteal lymph node (PLN) assay. With this assay a direct toxic effect of STZ on the pancreatic beta-cells was dissociated from the effects exerted on the immune system. Subcutaneous injections of STZ induced immune reactivity in the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
10
0

Year Published

1989
1989
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(11 citation statements)
references
References 0 publications
1
10
0
Order By: Relevance
“…Transfer of activated spleen cells from LDSTZ-D mice produced diabetes in recipients after a single low dose of STZ (24). STZ-specific immune reactions could be demonstrated by a popliteal lymph node assay indicating immune reactivity stimulated by STZ as an exogenous agent (25). However, depletion of T-lymphocytes alone, although able to temporarily protect from LDSTZ-D, was not sufficient to prevent the development of hyperglycemia (26).…”
Section: Discussionmentioning
confidence: 97%
“…Transfer of activated spleen cells from LDSTZ-D mice produced diabetes in recipients after a single low dose of STZ (24). STZ-specific immune reactions could be demonstrated by a popliteal lymph node assay indicating immune reactivity stimulated by STZ as an exogenous agent (25). However, depletion of T-lymphocytes alone, although able to temporarily protect from LDSTZ-D, was not sufficient to prevent the development of hyperglycemia (26).…”
Section: Discussionmentioning
confidence: 97%
“…STZ, a nitrosourea derivative approved for the treatment of carcinoid and pancreatic islet cell tumors, is known to induce type I diabetes in both animals (Like and Rossini 1976;Cheta 1998) and man (Schulz et al 1990). STZ was repeatedly shown to induce markedly positive PLN responses (Klinkhammer et al 1988;Verdier et al 1990;Krzystyniak et al 1992a, b;Brouland et al 1994;Patriarca et al 1994;Vial et al 1997;Aida et al 1998) and is therefore considered a prototypic reference compound in the PLN assay.…”
Section: Discussionmentioning
confidence: 97%
“…STZ was repeatedly shown to cause strongly positive PLN responses in rats and mice (Klinkhammer et al 1988;Verdier et al 1990;Krzystyniak et al 1992a, b;Brouland et al 1994;Patriarca et al 1994;Vial et al 1997;Aida et al 1998). As mentioned above, a pseudoGvH reaction is presumably involved.…”
Section: Introductionmentioning
confidence: 94%
“…To investigate the tracer accumulation in inflammatory LNs, two different lymphadenitis models, a chronic streptozotocin (STZ)-induced lymphadenitis model [17] and an acute concanavalin A (Con A) lymphadenitis model [18] were established.…”
Section: Methodsmentioning
confidence: 99%